ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2907

The Natural History of Thrombotic Events in Systemic Lupus Erythematosus and Associated Risk Factors

Katharine Hickman1, Laurence S Magder2 and Michelle Petri3, 1University College London, London, United Kingdom, 2University of Maryland School of Medicine, Baltimore, MD, 3Rheumatology, Johns Hopkins University Hospital, Baltimore, MD

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: SLE and thrombosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment Poster Session III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Prospective cohort studies of the natural history of thrombosis in SLE, including events before diagnosis are rare. No previous study has identified risk factors prospectively for both venous and arterial thrombosis. In this study we used a large prospective SLE cohort to assess the natural history of both arterial and venous thrombosis before and after the diagnosis of SLE.

Methods: 2305 SLE patients were enrolled in a prospective cohort. Medical records were reviewed to identify the occurrence of arterial and venous thrombosis prior to cohort entry. During participation in the Lupus Cohort, arterial thrombosis was diagnosed by patient history, diagnostic enzymes tests and imaging, including arteriogram, and venous thrombosis by ultrasound, CT or venography. We calculated the rate of thrombosis per person-year in periods of follow-up defined by time since diagnosis with SLE.

Results:

The highest rates of both venous thrombosis and arterial thrombosis were observed in the 2 years before and the 2 years after diagnosis: 8.9-10.5 per 1000 patient years for arterial thrombosis and 11.4-12.5 per 1000 patient years for venous thrombosis. A second peak in incidence of arterial thrombosis (11.8 per 1000 patient years) was observed later in the course of SLE.

Table 1: Rates of Venous and Arterial Thrombosis by Time since SLE Diagnosis

 

 

Venous Thrombosis

Arterial Thrombosis

Time since SLE diagnosis

# Events

Number of Person-Years

Rate of events per 1000 person-years

Rate Ratios (95% CI) adjusted for age

# Events

Number of Person-Years

Rate of events per 1000 person-years

Rate Ratios (95% CI) adjusted for age

> 5 years before SLE diagnosis

49

39,704

1.2

1.0 (Ref. Grp)

16

40,128

0.4

1.0 (Ref. Grp)

2-5 years before SLE diagnosis

15

6,490

2.3

1.5 (0.8, 2.7)

12

6,610

1.8

3.5 (1.6, 7.4)

0-2 years before SLE diagnosis

50

4,370

11.4

7.0 (4.7, 10.5)

40

4,472

8.9

15.9 (8.8, 28.8)

0-2 years after SLE diagnosis

51

4,087

12.5

7.4 (5.0, 11.1)

44

4,194

10.5

17.7 (9.9, 31.9)

2-5 years after SLE diagnosis

35

5,194

6.7

3.9 (2.5, 6.1)

24

5,364

4.5

7.2 (3.7, 13.8)

5+ years after SLE diagnosis

139

15,274

9.1

5.0 (3.5, 7.2)

183

15,481

11.8

15.8 (9.2, 27.3)

Conclusion: This large cohort study indicated that prevention of both venous and arterial thrombosis is important around the time of diagnosis of SLE. Monitoring for thrombosis should occur throughout the disease course, being mindful of the arterial thrombosis risk with longer duration of SLE. Our results suggest that the mechanism of events before diagnosis is not just accelerated atherosclerosis as suggested by some investigators. Accelerated atherosclerosis would not explain the increase in both arterial and venous events that occurs before and at diagnosis. Hypercoagulability appears to be the major explanatory mechanism.


Disclosure: K. Hickman, None; L. S. Magder, None; M. Petri, None.

To cite this abstract in AMA style:

Hickman K, Magder LS, Petri M. The Natural History of Thrombotic Events in Systemic Lupus Erythematosus and Associated Risk Factors [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-natural-history-of-thrombotic-events-in-systemic-lupus-erythematosus-and-associated-risk-factors/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-natural-history-of-thrombotic-events-in-systemic-lupus-erythematosus-and-associated-risk-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology